ArticleMedComm2026

Chemoimmunotherapy Combined With Antiangiogenic Therapy in Advanced Triple-Negative Breast Cancer: Real-World Outcomes From a Retrospective Cohort Study.

Yudong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.